These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18971119)

  • 1. Exogenous and endogenous hormones and breast cancer.
    Chen WY
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):573-85. PubMed ID: 18971119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
    Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
    Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
    Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
    Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous sex hormones and risk of breast cancer.
    Smetnik V; Konovalova V
    Gynecol Endocrinol; 2010 Mar; 26(3):149-51. PubMed ID: 19626508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone replacement therapy and breast cancer].
    Dobashi K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy and breast cancer.
    Jacobs HS
    Medscape Womens Health; 2000; 5(4):E2. PubMed ID: 11109047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and breast cancer.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bundred NJ; Morris J
    Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
    [No Abstract]   [Full Text] [Related]  

  • 14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers.
    Ganmaa D; Sato A
    Med Hypotheses; 2005; 65(6):1028-37. PubMed ID: 16125328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and endometrial cancer.
    Emons G; Huschmand-Nia A; Krauss T; Hinney B
    Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.
    Shapiro S; Farmer RD; Mueck AO; Seaman H; Stevenson JC
    J Fam Plann Reprod Health Care; 2011 Oct; 37(4):225-30. PubMed ID: 21642263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee opinion: number 262, December 2001. Risk of breast cancer with estrogen-progestin replacement therapy.
    ACOG Committee on Gynelogical Practice
    Obstet Gynecol; 2001 Dec; 98(6):1181-4. PubMed ID: 11755583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perimenopausal use of reproductive hormones effects on breast and endometrial cancer.
    Collins JA; Schlesselman JJ
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):511-25. PubMed ID: 12353671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.